Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 2;16(1):19.
doi: 10.1186/s13036-022-00299-4.

Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation

Affiliations
Review

Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation

Haryana Y Thomas et al. J Biol Eng. .

Abstract

Diabetic nephropathy, a kidney complication arising from diabetes, is the leading cause of death in diabetic patients. Unabated, the growing epidemic of diabetes is increasing instances of diabetic nephropathy. Although the main causes of diabetic nephropathy have been determined, the mechanisms of their combined effects on cellular and tissue function are not fully established. One of many damages of diabetic nephropathy is the development of fibrosis within the kidneys, termed mesangial expansion. Mesangial expansion is an important structural lesion that is characterized by the aberrant proliferation of mesangial cells and excess production of matrix proteins. Mesangial expansion is involved in the progression of kidney failure in diabetic nephropathy, yet its causes and mechanism of impact on kidney function are not well defined. Here, we review the literature on the causes of mesangial expansion and its impacts on cell and tissue function. We highlight the gaps that still remain and the potential areas where bioengineering studies can bring insight to mesangial expansion in diabetic nephropathy.

Keywords: Chronic kidney disease; Collagen accumulation; Diabetic kidney disease; Extracellular matrix; Glomerulus; Mesangial cell; Mesangial matrix; Mesangium; Renal fibrosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Mesangial cell structure with its processes extending out to multiple capillaries. MC: mesangial cell, MM: mesangial matrix, P: podocytes, EC: endothelial cells, C: capillaries, GBM: glomerular basement membrane. The small arrows indicate the mesangial cell/GBM connections that oppose the hydrostatic pressures shown by long red arrow. The T-shaped marking indicates the mesangial cell process where the body of the T-shaped marking represents the axis of the mesangial processes, and the head of the T-shaped marking indicates the mesangial angles. The mesangial cell occupies a majority of the mesangium and is closely attached to the GBM directly by microfibrillar attachments or indirectly to the GBM via the mesangial matrix. The T-shaped mesangial processes are firmly embedded in between the capillaries and the GBM and enable the mesangial cell to maintain glomerular structure. Modified after [75] with permission
Fig. 2
Fig. 2
A representation of the multiscale process that governs mesangial expansion from the molecular level (yellow) to the cellular level (orange) and tissue level (blue). Interactions between these different scales are important, especially the feedback influence of changes in mesangial matrix structure, composition, and stiffness on mesangial cell behavior. Ang II: angiotensin II, HG: hyperglycemia
Fig. 3
Fig. 3
The role of the mesangial matrix in regulating mesangial cell phenotype, proliferation, and collagen accumulation. Structural and compositional alterations to the mesangial matrix cause the activation of the mesangial cell, which enhances proliferation and collagen I production. TGF- β production by the activated mesangial cell causes mesangial cell hypertrophy and prevention of mesangial cell proliferation. MC: mesangial cell, MM: mesangial matrix, TGF- β: transforming growth factor beta. Pointed arrows represent enhancement, and flathead arrows indicate inhibition

Similar articles

Cited by

References

    1. Jitraknatee J, Ruengorn C, Nochaiwong S. Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: a cross-sectional study in primary care practice. Sci Rep. 2020;10(1):1–10. doi: 10.1038/s41598-020-63443-4. - DOI - PMC - PubMed
    1. Daehn IS. Glomerular endothelial cell stress and cross-talk with podocytes in early diabetic kidney disease. Front Med. 2018;5:76. doi: 10.3389/fmed.2018.00076. - DOI - PMC - PubMed
    1. Zent R, Yan X, Su Y, Hudson BG, Borza DB, Moeckel GW, Qi Z, Sado Y, Breyer MD, Voziyan P, Pozzi A. Glomerular injury is exacerbated in diabetic integrin α1-null mice. Kidney Int. 2006;70(3):460–70. doi: 10.1038/sj.ki.5000359. - DOI - PubMed
    1. Klemis V, Ghura H, Federico G, Würfel C, Bentmann A, Gretz N, Miyazaki T, Gröne HJ, Nakchbandi IA. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes. Kidney Int. 2017;91(6):1374–85. doi: 10.1016/j.kint.2016.12.006. - DOI - PubMed
    1. McCarthy KJ, Routh RE, Shaw W, Walsh K, Welbourne TC, Johnson JH. Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion. Kidney Int. 2000;58(6):2341–50. doi: 10.1046/j.1523-1755.2000.00418.x. - DOI - PubMed

LinkOut - more resources